The phrase “variety two inflammation” continues to be utilized to explain this eosinophilic pathway for inflammation during the individual with bronchial asthma, which happens to be differentiated from non-variety 2 inflammation, regarded as predominantly related to neutrophilic or paucigranulocytic sputum phenotypes, and with most likely diver